Objective: Vaccines prevent many cases of infectious disease, yet immunization campaigns are hindered by various barriers. This work presents the results of a quality improvement project addressing barriers to vaccine compliance in an underserved teaching practice by reducing missed opportunities and increasing provider and patient compliance rates for pneumococcal, Tdap, influenza, and zoster vaccines in adults.
Introduction
Vaccines are among the greatest advances in modern medicine, and have prevented many cases of infectious diseases, yet vaccination campaigns are hindered by various barriers and require consistent evaluation and innovation.
The Healthy People 2020 (HP2020) program is an important US public health effort to promote health, reduce disparities, and advance research. Among the objectives of HP2020 is to: "Reduce, eliminate, or maintain elimination of cases of vaccine-preventable diseases [1] ." The influenza (flu) vaccine is an example of an effective, but underused Sidani et al. 
ORIGINAL RESEARCH
immunization. Even though vaccines are widely available, affordable, and efficacious, influenza continues to take a dramatic toll on the unvaccinated each year, impacting high-risk populations and the elderly with hospitalization, death, and economic burden [2, 3] .
Barriers to immunization compliance are numerous, including knowledge and attitudes of patients and providers, economic concerns, access to care [2, 3] , and racial disparities [4] . Many practices face challenges to provider compliance with evidence-based guidelines, including lack of awareness or familiarity with guidelines, lack of agreement, lack of self-efficacy and outcome expectancy, and external barriers, including patient and environmental factors [4] . Situational constraints, such as presenting illness, also limit the ability of providers to administer vaccines during a given clinical encounter. Teaching practices face additional challenges, as medical residents may not assign high priority to adult immunizations because vaccines may be not highly valued or the use of vaccines closely monitored [3] .
Other common reasons patients forego vaccination include the belief that healthy people do not need vaccinations, concerns over side effects, and reporting that their physician did not recommend vaccinations [5] . Indeed, only one-fourth of primary care physicians issued influenza vaccination reminders during the 2011-2012 influenza season [6] . Patient fear of vaccine risk is also a factor in declining recommended vaccines. For example, a common concern is that the influenza vaccine can cause the flu; however, inactivated influenza vaccine does not cause the flu, although injection site swelling, redness, and tenderness are possible [7] . Although the liveattenuated nasal spray flu vaccine contains live virus and has a greater potential for side effects, the live-attenuated nasal spray flu vaccine does not cause influenza either [8] . This common misconception may be partially attributable to the concurrent onset of other seasonal illnesses, perceived as flu, following vaccination [2] . Similarly, misconceptions about mercury toxicity in vaccine formulations are prevalent [2] . Concerns about egg allergies remain, but such myths have been diminished by recent studies [6] . Risk of adverse reactions is higher in allergic or immunocompromised patients, and also in young children. The Centers for Disease Control and Prevention (CDC) recommends screening and using evidence-based precautions to decrease such reactions [7] . One unresolved concern is that influenza vaccine may cause Guillain-Barré syndrome, and research into this association is ongoing [9] .
The current study is the result of a quality improvement project designed to systematically address perceived barriers to adult vaccine compliance in an underserved teaching practice. This was accomplished by reducing missed opportunities and increasing both provider and patient knowledge and compliance. Similar to national rates, the baseline immunization rates at the study practice were low compared to HP2020 goals [1] , and therefore represented an opportunity for improvement.
The intervention aimed to improve immunization rates over the course of 1 year by enhancing provider and patient knowledge, soliciting and addressing patient concerns, and reducing missed clinical opportunities. Although the HP2020 goals cover a wide range of infectious diseases for all age groups, this work focused on rates of pneumococcal, Td or Tdap, influenza, and zoster vaccines in adults.
Methods
The study was a quality improvement project conducted in an underserved urban family medicine residency practice from 4 ORIGINAL RESEARCH population tends to be the most underserved members within these communities, predominantly uninsured, underinsured, or publicly insured, and primarily members of minority communities. Specifically, the rate of self-pay was 8.6%, publicly insured was 53.4%, and charity care offered by the affiliated hospital system was 10.3%. The racial distribution was approximately 53% African American, 30% Latino, and 17% Caucasian. De-identified lists were used to aggregate all data points. Data analysis was conducted using a simple Z-test for proportions with significance set at a 95% confidence level.
Results
Outcome evaluations were based on several parameters, and split into administrative processes and clinical outcomes. line. An overview of clinical outcomes is shown in Table 1 .
Vaccination rates improved, but with mixed results
with respect to reaching the target of one-half the difference between baseline and HP2020 goals for each vaccine. The rates of patient refusal for vaccines were mixed with respect to the direction of change, significance, and reaching the 10% reduction target. The baseline refusal rate for influenza was 14.5% and the end refusal rate post-intervention was 11.1%, which was a significant improvement of 3.4% and exceeded the 10% target of reduction of 13.1%. The baseline refusal rate for PPSV was 9.9% and the end result was 9.2% (a 0.7% improvement). This result was not significant, nor did it reach the target of 8.9%. The baseline refusal rate for Td or Tdap was 6.8% and the end result was 6.9%; this result was actually slightly worse than baseline, but the difference was not significant. The target was 6.1%. The baseline refusal rate for zoster was 20.9% and the end result was 15.4%, which was Missed opportunities all improved, but significance was mixed, and none reached the target of a 50% reduction from baseline. The baseline missed opportunity rate for influenza was 61.1%, and the end result was 53.7%, which was a significant improvement of 7.4% (target=30.5%). The baseline missed opportunity rate for PPSV was 25.4%, and the end result was 16.8%, which was a significant improvement of 8.6%
(target=12.7%). The baseline missed opportunity rate for Td or Tdap was 52.9%, and the end result was 40.2%, which was a significant improvement of 12.7% (target=26.5%). The baseline missed opportunity rate for zoster was 63.9%, and the end result was 61.6%, which was an improvement of 2.3%. This result was neither significant nor reached the target of 31.9%.
Our study showed that the pre-visit review by the QA nurse had significant changes in refusals and missed opportunities regarding the influenza vaccination (Table 2) . It has been shown that standing orders for nurse recommendations are a significant patient motivator, further enhanced by physician follow-up [10, 11] .
This study was conducted as a retrospective review of outcomes from a clinical and training quality improvement project. As such, the study was granted exemption from human subjects research requirements by the Baylor College of Medicine Institutional Review Board.
Discussion
Nationally, influenza vaccination among adults is estimated to be less than 40% in the 2010-2011 and 2011-2012 flu seasons, although the HP2020 goal is 70% [1] . Similarly, the rates of other common adult immunizations are suboptimal. For example, PPSV coverage among non-institutionalized adults >65 years of age is 60% overall, although the HP2020 goal is 90% [1] . The shingles (herpes zoster) vaccine for adults >60 years of age has a national administration rate of 6.7% and a HP2020 target of 30%. In 2012, the percentage of adults >19 years of age who received Tdap in the previous 7 years was approximately 14.2%; however, there was no associated HP2020 goal for Tdap vaccination [3] .
Chatterjee and O'Keefe [12] suggested that because of the successes of immunizations in recent decades and fading memory of the incidence of some diseases, there appears to be a shift away from the fear of disease to a fear of vaccines. This is evidenced by the public controversies surrounding parents and even healthcare providers opting not to vaccinate children and themselves based on common misconceptions [12, 13] .
The intervention in this study was aimed in part to address this phenomenon.
Our results were generally encouraging, indicating the value of a dual-pronged approach to adherence, thus address- vaccine administration was recorded in the wrong section of the chart note, it was reflected as a missed opportunity in the study. The burden of documentation is significant on providers, and future study should focus on methods to ease documentation. Additionally, even though outreach to high-risk groups was conducted, tracking of PPSV for high-risk groups was not possible because of difficulties with data extraction from the medical record, and thus was not reported separately.
Subjective feedback from providers was positive, with anecdotal reports of increased resident provider confidence in counselling patients, improved documentation practices, and greater patient compliance. In this study, vaccination rates all improved significantly, and other outcomes were encouraging, although it is clear that there remains a significant challenge to reaching HP2020 goals within the study population and nationally.
